Enanta Pharmaceuticals Inc

NASDAQ:ENTA   3:59:51 PM EDT
49.84
+2.57 (+5.44%)
Products

Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer

Published: 06/21/2022 21:08 GMT
Enanta Pharmaceuticals Inc (ENTA) - Press Release- Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer.
Enanta Pharmaceuticals Inc - Seeks Fair Compensation for Pfizer's Use of a Coronavirus 3cl Protease Inhibitor Claimed in '953 Patent.
Enanta - Seeking Damages for Infringement of '953 Patent in Manufacture, Use,sale of Pfizer's Covid-19 Antiviral, Paxlovid.